Biomea Fusion BMEA
NASDAQ BMEA
$0.58 +0.03 (+5.92%)
As of: Nov 11, 2026 · 11:17 AM EST

Biomea Fusion (BMEA) Other financing activities (as filed) (2021 - 2025)

Updated

Biomea Fusion's Other financing activities came in at $628,000 for Q3 2025, up 423.3% from the prior quarter.

Analysis

Biomea Fusion (BMEA) Other financing activities (as filed) (2021 - 2025) Analysis & Trends

Over the trailing twelve months to Sep 30, 2025, Biomea Fusion reported Other financing activities of $753,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Biomea Fusion 39.97 Mn -121.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -628,000.00
Jun 30, 2025 -120,000.00
Mar 31, 2025 -5,000.00
Mar 31, 2021 -3,000.00
API Access

Biomea Fusion Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=BMEA&period=max&api_key=YOUR_API_KEY